Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Oct;37(10):2139–2143. doi: 10.1128/aac.37.10.2139

Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers.

R E Polk 1, D Israel 1, J Wang 1, J Venitz 1, J Miller 1, J Stotka 1
PMCID: PMC192241  PMID: 8257136

Abstract

The purpose of the present study was to assess the cutaneous response to intradermally administered vancomycin in healthy adults and to determine whether the magnitude of the cutaneous response correlated to the severity of "red man syndrome" (RMS) following intravenous administration of vancomycin to the same subjects. Eleven healthy males were skin tested with intradermally administered histamine and saline controls and intradermally administered vancomycin at different concentrations. Vancomycin caused a dose-dependent area of flare in all subjects. The sigmoidal maximal flare model was used to fit each dose-response curve, and cutaneous responsiveness to vancomycin was quantified by various methods, including the flare area at each dose, maximum flare area (maximal flare), dose required to produce 50% of maximum flare, dose required to produce a flare area of 400 mm2, and the slope of the dose-response curve. One week after skin testing, subjects received an infusion of vancomycin, 15 mg/kg of body weight over 60 min. For the assessment of the severity of RMS, we used previously described methods. Although all subjects experienced erythema from the intravenously administered vancomycin and 10 subjects had pruritus, there was no significant correlation between vancomycin skin test results and the severity of RMS. We conclude that vancomycin skin tests do not predict the severity of RMS. In addition, vancomycin skin tests may be of no benefit for assessing immunoglobulin E-mediated allergy to vancomycin, since all subjects had a positive reaction at concentrations of > or = 10 micrograms/ml.

Full text

PDF
2139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer C. B., MacDonald D. M., Morley J., Page C. P., Paul W., Sanjar S. Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man. Br J Pharmacol. 1985 May;85(1):109–113. doi: 10.1111/j.1476-5381.1985.tb08836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chandler M. J., Grammer L. C., Patterson R. Provocative challenge with local anesthetics in patients with a prior history of reaction. J Allergy Clin Immunol. 1987 Jun;79(6):883–886. doi: 10.1016/0091-6749(87)90236-3. [DOI] [PubMed] [Google Scholar]
  3. Cohen R. W., Rosenstreich D. L. Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J Allergy Clin Immunol. 1986 Jun;77(6):802–807. doi: 10.1016/0091-6749(86)90377-5. [DOI] [PubMed] [Google Scholar]
  4. Fahmy N. R. Hemodynamics, plasma histamine, and catecholamine concentrations during an anaphylactoid reaction to morphine. Anesthesiology. 1981 Sep;55(3):329–331. doi: 10.1097/00000542-198109000-00028. [DOI] [PubMed] [Google Scholar]
  5. Fisher M. Intradermal testing after anaphylactoid reaction to anaesthetic drugs: practical aspects of performance and interpretation. Anaesth Intensive Care. 1984 May;12(2):115–120. doi: 10.1177/0310057X8401200205. [DOI] [PubMed] [Google Scholar]
  6. Flacke J. W., Flacke W. E., Bloor B. C., Van Etten A. P., Kripke B. J. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg. 1987 Aug;66(8):723–730. [PubMed] [Google Scholar]
  7. Galletly D. C. Comparative cutaneous histamine release by neuromuscular blocking agents. Anaesth Intensive Care. 1986 Nov;14(4):365–369. doi: 10.1177/0310057X8601400407. [DOI] [PubMed] [Google Scholar]
  8. Galletly D. C., Treuren B. C. Anaphylactoid reactions during anaesthesia. Seven years' experience of intradermal testing. Anaesthesia. 1985 Apr;40(4):329–333. [PubMed] [Google Scholar]
  9. Galletly D. C., Treuren B. C. Cutaneous sensitivity to atracurium and vecuronium in patients suffering anaphylactoid reactions to neuromuscular blockers. Anaesth Intensive Care. 1985 Aug;13(3):305–310. doi: 10.1177/0310057X8501300311. [DOI] [PubMed] [Google Scholar]
  10. Healy D. P., Polk R. E., Garson M. L., Rock D. T., Comstock T. J. Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers. Antimicrob Agents Chemother. 1987 Mar;31(3):393–397. doi: 10.1128/aac.31.3.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levy J. H., Adelson D., Walker B. Wheal and flare responses to muscle relaxants in humans. Agents Actions. 1991 Nov;34(3-4):302–308. doi: 10.1007/BF01988720. [DOI] [PubMed] [Google Scholar]
  12. Levy J. H., Kettlekamp N., Goertz P., Hermens J., Hirshman C. A. Histamine release by vancomycin: a mechanism for hypotension in man. Anesthesiology. 1987 Jul;67(1):122–125. doi: 10.1097/00000542-198707000-00026. [DOI] [PubMed] [Google Scholar]
  13. Levy J. H., Roizen M. F., Morris J. M. Anaphylactic and anaphylactoid reactions. A review. Spine (Phila Pa 1976) 1986 Apr;11(3):282–291. doi: 10.1097/00007632-198604000-00017. [DOI] [PubMed] [Google Scholar]
  14. Lin R. Y. Desensitization in the management of vancomycin hypersensitivity. Arch Intern Med. 1990 Oct;150(10):2197–2198. [PubMed] [Google Scholar]
  15. Nelson H. S. Diagnostic procedures in allergy. I. Allergy skin testing. Ann Allergy. 1983 Oct;51(4):411–418. [PubMed] [Google Scholar]
  16. North F. C., Kettelkamp N., Hirshman C. A. Comparison of cutaneous and in vitro histamine release by muscle relaxants. Anesthesiology. 1987 Apr;66(4):543–546. doi: 10.1097/00000542-198704000-00016. [DOI] [PubMed] [Google Scholar]
  17. Pfaller M. A., Krogstad D. J., Granich G. G., Murray P. R. Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. J Clin Microbiol. 1984 Sep;20(3):311–316. doi: 10.1128/jcm.20.3.311-316.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Polk R. E. Anaphylactoid reactions to glycopeptide antibiotics. J Antimicrob Chemother. 1991 Apr;27 (Suppl B):17–29. doi: 10.1093/jac/27.suppl_b.17. [DOI] [PubMed] [Google Scholar]
  19. Polk R. E., Healy D. P., Schwartz L. B., Rock D. T., Garson M. L., Roller K. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis. 1988 Mar;157(3):502–507. doi: 10.1093/infdis/157.3.502. [DOI] [PubMed] [Google Scholar]
  20. Rybak M. J., Bailey E. M., Warbasse L. H. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin. Antimicrob Agents Chemother. 1992 Jun;36(6):1204–1207. doi: 10.1128/aac.36.6.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schatz M. Skin testing and incremental challenge in the evaluation of adverse reactions to local anesthetics. J Allergy Clin Immunol. 1984 Oct;74(4 Pt 2):606–616. doi: 10.1016/0091-6749(84)90114-3. [DOI] [PubMed] [Google Scholar]
  22. Sciberras D. G., Goldenberg M. M., Bolognese J. A., James I., Baber N. S. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation. Br J Clin Pharmacol. 1987 Dec;24(6):753–761. doi: 10.1111/j.1365-2125.1987.tb03242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wallace M. R., Mascola J. R., Oldfield E. C., 3rd Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis. 1991 Dec;164(6):1180–1185. doi: 10.1093/infdis/164.6.1180. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES